NCT02501187

Brief Summary

Blepharoptosis, inferodisplacement of the upper eyelid, can be congenital or acquired. Acquired Blepharoptosis is usually aponeurotic, due to stretching or disinsertion of the levator aponeurosis. Treatment is surgical and can be performed by three common procedures - Levator advancement, Müller's muscle-conjunctival resection procedure and White line advancement. A number of reports inspected the possibility that Blepharoptosis repair procedures may cause deterioration in dry eye status. The investigators would like to assess whether there is a difference between the different procedures in their influence on dry eye status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 17, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

October 8, 2015

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

April 13, 2018

Status Verified

April 1, 2018

Enrollment Period

4.7 years

First QC Date

July 12, 2015

Last Update Submit

April 11, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of objective or subjective deterioration in dry eye status

    Dry eye status will be measured by a composite of tests, including Ocular surface disease index (OSDI) questionnaire (which indicates subjective status), and a number of objective tests - Shirmer test, Flurocein dye, Lissamine green dye and tear breakup time

    6 months

Secondary Outcomes (1)

  • Ptosis repair procedure success

    6 months

Study Arms (3)

Patients operated for ptosis by levator advancement

EXPERIMENTAL

patients undergoing surgical repair for aponeurotic ptosis by the procedure- levator advancement.

Procedure: Levator advancement

Patients operated for ptosis by white line advancement

EXPERIMENTAL

patients undergoing surgical repair for aponeurotic ptosis by the procedure- white line advancement

Procedure: White line advancement

Patients operated for ptosis by Müller resection

EXPERIMENTAL

patients undergoing surgical repair for aponeurotic ptosis by the procedure- Müller's muscle-conjunctival resection.

Procedure: Müller's muscle-conjunctival resection procedure

Interventions

A transcutaneous procedure in which the Levator palpebrae aponeurosis is advanced and attached to the tarsus.

Patients operated for ptosis by levator advancement

A transconjunctival procedure in which part of the muller muscle and conjunctiva are resected.

Patients operated for ptosis by Müller resection

A transconjunctival procedure in which the Levator palpebrae aponeurosis is advanced and attached to the tarsus.

Patients operated for ptosis by white line advancement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ptosis which indicate surgical repair
  • The ptosis must be suitable for repair in any of the procedures

You may not qualify if:

  • Systemic disease which may cause ocular surface disease (eg Sjogren disease)
  • Previous orbital or eyelid surgery
  • Significantly dry eyes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmology clinics, Rabin Medical Center

Petah Tikva, Israel

RECRUITING

MeSH Terms

Conditions

Blepharoptosis

Condition Hierarchy (Ancestors)

Eyelid DiseasesEye Diseases

Study Officials

  • Maya Eiger, MD

    Rabin Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

July 12, 2015

First Posted

July 17, 2015

Study Start

October 8, 2015

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

April 13, 2018

Record last verified: 2018-04

Locations